Mantle cell lymphoma trials in Norway
1 trial · From EU CTIS (euclinicaltrials.eu), checked 14 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peoplePIRTOBRUTINIB AND GLOFITAMAB IN MANTLE CELL LYMPHOMA
- Where
- Oslo, Trondheim
- Age
- 18 years and over
- People
- 96 worldwide
- Run by
- Klinikum der Universitaet Muenchen AöR
See details and how to join2024-512922-27-00